Literature DB >> 23053149

[Radiotherapy of non-malignant diseases. Past, present and future].

M H Seegenschmiedt1, O Micke.   

Abstract

Mesh：

Year:  2012        PMID： 23053149     DOI： 10.1007/s00066-012-0195-z

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  75 in total

1.  Assessment of a carcinogenic risk for treatment of Graves' ophthalmopathy in dependence on age and irradiation geometry.

Authors:  J J Broerse; A Snijders-Keilholz; J T Jansen; J Zoetelief; C Klein; M H Seegenschmiedt
Journal:  Radiother Oncol       Date:  1999-12       Impact factor: 6.280

Review 2.  [The role of external beam radiation therapy in the adjuvant treatment of pigmented villonodular synovitis].

Authors:  R Heyd; M H Seegenschmiedt; O Micke
Journal:  Z Orthop Unfall       Date:  2011-01-26       Impact factor: 0.923

3.  The powerful placebo.

Authors:  H K BEECHER
Journal:  J Am Med Assoc       Date:  1955-12-24

Review 4.  Prevention of pterygium recurrence by postoperative single-dose beta-irradiation: a prospective randomized clinical double-blind trial.

Authors:  Ina M Jürgenliemk-Schulz; Lidy J C Hartman; Judith M Roesink; Robbert J H A Tersteeg; Ingeborg van Der Tweel; Henk B Kal; Maarten P Mourits; Harm K Wyrdeman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-07-15       Impact factor: 7.038

5.  Estimation of the carcinogenic risk of radiotherapy of benign diseases from shoulder to heel.

Authors:  Jan Th M Jansen; Johan J Broerse; Johannes Zoetelief; Claudia Klein; Heinrich M Seegenschmiedt
Journal:  Radiother Oncol       Date:  2005-09       Impact factor: 6.280

6.  Radiotherapy of non-malignant disorders: where do we stand?

Authors:  Jan Willem Leer; Paul van Houtte; Heinrich Seegenschmiedt
Journal:  Radiother Oncol       Date:  2007-05-08       Impact factor: 6.280

7.  Mortality from cancer and other causes after radiotherapy for ankylosing spondylitis.

Authors:  W M Brown; R Doll
Journal:  Br Med J       Date:  1965-12-04

8.  Radiotherapy for prevention and therapy of gynecomastia due to antiandrogen treatment in prostate cancer patients: a patterns-of-care study.

Authors:  Burkhard Neu; Verena Sautter; Felix Momm; Ute Melcher; Heinrich Seegenschmiedt; Oliver Micke; Marie-Luise Sautter-Bihl
Journal:  Strahlenther Onkol       Date:  2011-11-29       Impact factor: 3.621

Review 9.  Radiotherapy for symptomatic vertebral hemangiomas: results of a multicenter study and literature review.

Authors:  Reinhard Heyd; M Heinrich Seegenschmiedt; Dirk Rades; Cornelia Winkler; Hans T Eich; Frank Bruns; Georg Gosheger; Normann Willich; Oliver Micke
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-08-21       Impact factor: 7.038

10.  Radiotherapy in painful heel spurs (plantar fasciitis)--results of a national patterns of care study.

Authors:  Oliver Micke; M Heinrich Seegenschmiedt
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-03-01       Impact factor: 7.038
View more
  10 in total

Review 1.  The efficacy and safety of low-dose radiotherapy on pain and functioning in patients with osteoarthritis: a systematic review.

Authors:  M J M Minten; E Mahler; A A den Broeder; J W H Leer; C H van den Ende
Journal:  Rheumatol Int       Date:  2015-08-08       Impact factor: 2.631

2.  Re-irradiation for painful heel spur syndrome. Retrospective analysis of 101 heels.

Authors:  M G Hautmann; U Neumaier; O Kölbl
Journal:  Strahlenther Onkol       Date:  2014-01-24       Impact factor: 3.621

3.  Re-irradiation for osteoarthritis-retrospective analysis of 217 joints.

Authors:  Matthias G Hautmann; Philipp Rechner; Matthias Hipp; Ulrich Neumaier; Felix Steger; Fabian Pohl; Markus Weber; Oliver Kölbl; Christoph Süß
Journal:  Strahlenther Onkol       Date:  2019-07-25       Impact factor: 3.621

4.  Long-term effect and prognostic factors of a low-dose radiotherapy of painful plantar calcaneal spurs : A retrospective unicenter study.

Authors:  Volker Rudat; Nikoleta Tontcheva; Gudrun Kutz; Tina Ojevwe Orovwighose; Erich Gebhardt
Journal:  Strahlenther Onkol       Date:  2021-01-27       Impact factor: 3.621

Review 5.  Low-dose splenic irradiation in symptomatic congestive splenomegaly: report of five cases with literature data.

Authors:  Frank Bruns; Michael Bremer; Arne Dettmer; Stefan Janssen
Journal:  Radiat Oncol       Date:  2014-03-27       Impact factor: 3.481

Review 6.  Radiotherapy for non-malignant disorders: state of the art and update of the evidence-based practice guidelines.

Authors:  M H Seegenschmiedt; O Micke; R Muecke
Journal:  Br J Radiol       Date:  2015-05-08       Impact factor: 3.039

Review 7.  Hormetic Response to Low-Dose Radiation: Focus on the Immune System and Its Clinical Implications.

Authors:  Jiuwei Cui; Guozi Yang; Zhenyu Pan; Yuguang Zhao; Xinyue Liang; Wei Li; Lu Cai
Journal:  Int J Mol Sci       Date:  2017-01-27       Impact factor: 5.923

8.  Radiotherapy for calcaneodynia, achillodynia, painful gonarthrosis, bursitis trochanterica, and painful shoulder syndrome - Early and late results of a prospective clinical quality assessment.

Authors:  Oliver Micke; Eyup Ugrak; Stefan Bartmann; Irenaeus A Adamietz; Ulrich Schaefer; Rebecca Bueker; Klaus Kisters; M Heinrich Seegenschmiedt; Khashayar Fakhrian; Ralph Muecke
Journal:  Radiat Oncol       Date:  2018-04-19       Impact factor: 3.481

Review 9.  Basics of Radiation Biology When Treating Hyperproliferative Benign Diseases.

Authors:  Franz Rödel; Claudia Fournier; Julia Wiedemann; Felicitas Merz; Udo S Gaipl; Benjamin Frey; Ludwig Keilholz; M Heinrich Seegenschmiedt; Claus Rödel; Stephanie Hehlgans
Journal:  Front Immunol       Date:  2017-05-03       Impact factor: 7.561

10.  Modulation of Inflammatory Reactions by Low-Dose Ionizing Radiation: Cytokine Release of Murine Endothelial Cells Is Dependent on Culture Conditions.

Authors:  Sabine Schröder; Stephan Kriesen; Daniel Paape; Guido Hildebrandt; Katrin Manda
Journal:  J Immunol Res       Date:  2018-06-03       Impact factor: 4.818
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.